NTRR Stock Overview
Neutra Corp. researches, develops, and provides hemp-derived products in the nutraceutical space.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Neutra Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0003 |
| 52 Week High | US$0.0007 |
| 52 Week Low | US$0.0002 |
| Beta | 3.21 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -25.00% |
| 3 Year Change | -93.33% |
| 5 Year Change | -97.64% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| NTRR | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -1.5% | -3.2% |
| 1Y | -25.0% | 9.7% | 19.3% |
Return vs Industry: NTRR underperformed the US Pharmaceuticals industry which returned 9.7% over the past year.
Return vs Market: NTRR underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| NTRR volatility | |
|---|---|
| NTRR Average Weekly Movement | 49.1% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NTRR's share price has been volatile over the past 3 months.
Volatility Over Time: NTRR's weekly volatility (49%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | Sydney Jim | neutrainc.com |
Neutra Corp. researches, develops, and provides hemp-derived products in the nutraceutical space. The company sells hemp-derived products, including products containing delta-8-THC and other cannabinoids, CBD sports creams, and other products. Neutra Corp. was incorporated in 2011 and is based in Sugar Land, Texas.
Neutra Corp. Fundamentals Summary
| NTRR fundamental statistics | |
|---|---|
| Market cap | US$875.37k |
| Earnings (TTM) | -US$474.97k |
| Revenue (TTM) | US$17.40k |
50.3x
P/S Ratio-1.8x
P/E RatioIs NTRR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NTRR income statement (TTM) | |
|---|---|
| Revenue | US$17.40k |
| Cost of Revenue | US$9.37k |
| Gross Profit | US$8.03k |
| Other Expenses | US$483.00k |
| Earnings | -US$474.97k |
Last Reported Earnings
Oct 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00016 |
| Gross Margin | 46.15% |
| Net Profit Margin | -2,730.19% |
| Debt/Equity Ratio | -7.1% |
How did NTRR perform over the long term?
See historical performance and comparison